Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BYSI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 3
22 filers reported a long position in BYSI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Decheng Capital LLC | $6.7M | 3.8M | Unchanged |
| BlackRock, Inc. | $1.2M | 672.9K | +3.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1M | 626.5K | +3% |
| GEODE CAPITAL MANAGEMENT, LLC | $643.9K | 367.7K | -2% |
| STATE STREET CORP | $404.5K | 231.1K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $317.1K | 181.2K | +0.7% |
| UBS Group AG | $110.3K | 63K | +5,287.4% |
| NORTHERN TRUST CORP | $108.5K | 62K | -10.5% |
| Meridian Wealth Management, LLC | $26.3K | 15K | Unchanged |
| Farther Finance Advisors, LLC | $22.4K | 12.8K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.